Guardant Health (GH) Total Non-Current Liabilities (2017 - 2026)
Guardant Health (GH) posted Total Non-Current Liabilities of $2.0 billion for Q2 2026, up 2.01% sequentially from $2.0 billion in Q1 2026, and up 29.87% YoY from $1.5 billion in Q2 2025.
Guardant Health (GH) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends
Guardant Health has reported Total Non-Current Liabilities for 10 years, with the latest figure at $2.0 billion in Q2 2026.
- Quarterly Total Non-Current Liabilities rose 29.87% year-over-year to $2.0 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.0 billion (up 29.87% YoY) and the FY2025 annual result came in at $2.0 billion, up 29.55% from the prior year.
- Total Non-Current Liabilities rose to $2.0 billion in Q2 2026 per GH's latest filing, from $2.0 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $2.0 billion in Q2 2026 and troughed at $1.5 billion in Q1 2025.
- A 5-year average of $1.6 billion and a median of $1.5 billion in 2023 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2024 and 2026: Total Non-Current Liabilities retreated 3.17% in 2024, then surged 31.03% in 2026.
- Over 5 years, Total Non-Current Liabilities stood at $1.5 billion in 2022, then slipped by 0.58% to $1.5 billion in 2023, then increased by 0.05% to $1.5 billion in 2024, then climbed by 29.55% to $2.0 billion in 2025, then grew by 1.16% to $2.0 billion in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $2.0 billion, $2.0 billion, and $2.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 108.64 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 85.84 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 715.49 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 5.45 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 22.94 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 542.10 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 6.36 Bn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 3.39 Bn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 9.19 Bn |
| 10 | Guardant Health | 22.38 Bn | 21.33 Bn | 219.03 Mn | 2.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.01 Bn |
| Mar 31, 2026 | 1.97 Bn |
| Dec 31, 2025 | 1.99 Bn |
| Sep 30, 2025 | 1.54 Bn |
| Jun 30, 2025 | 1.55 Bn |
| Mar 31, 2025 | 1.50 Bn |
| Dec 31, 2024 | 1.53 Bn |
| Sep 30, 2024 | 1.51 Bn |
| Jun 30, 2024 | 1.52 Bn |
| Mar 31, 2024 | 1.54 Bn |
| Dec 31, 2023 | 1.53 Bn |
| Sep 30, 2023 | 1.56 Bn |
| Jun 30, 2023 | 1.54 Bn |
| Mar 31, 2023 | 1.55 Bn |
| Dec 31, 2022 | 1.54 Bn |
| Sep 30, 2022 | 1.53 Bn |
| Jun 30, 2022 | 1.53 Bn |
| Mar 31, 2022 | 1.59 Bn |
| Dec 31, 2021 | 1.56 Bn |
| Sep 30, 2021 | 1.45 Bn |